Corrigendum to ‘Repurposing the anticancer drug mitomycin C for the treatment of persistent Acinetobacter baumannii infections’ (International Journal of Antimicrobial Agents (2017) 49(1) (88–92), (S092485791630276X) (10.1016/j.ijantimicag.2016.08.022))

Martha Yumiko Cruz-Muñiz, Luis Esau López-Jacome, Melissa Hernández-Durán, Rafael Franco-Cendejas, Paula Licona-Limón, Jose Luis Ramos-Balderas, Mariano Martinéz-Vázquez, Javier A. Belmont-Díaz, Thomas K. Wood, Rodolfo García-Contreras

Research output: Contribution to journalComment/debatepeer-review

1 Scopus citations

Abstract

The authors regret that it was stated by mistake that all isolates were obtained from burned patients, however, the following isolates were obtained from a different source: A552, A571, A574 orthopedic patients, A573, A578 column surgery, A556 hip and knee surgery, A553 traumatology and A563 nasogastric aspirate. The authors would like to apologise for any inconvenience caused.

Original languageEnglish (US)
Pages (from-to)868
Number of pages1
JournalInternational Journal of Antimicrobial Agents
Volume52
Issue number6
DOIs
StatePublished - Dec 2018

All Science Journal Classification (ASJC) codes

  • Microbiology (medical)
  • Infectious Diseases
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Corrigendum to ‘Repurposing the anticancer drug mitomycin C for the treatment of persistent Acinetobacter baumannii infections’ (International Journal of Antimicrobial Agents (2017) 49(1) (88–92), (S092485791630276X) (10.1016/j.ijantimicag.2016.08.022))'. Together they form a unique fingerprint.

Cite this